LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 Radicicol
3.33
uM
LJP6
 0.2833 0.0268 -0.0394 0.0531
BT-20 Seliciclib
3.33
uM
LJP5
 0.8149 0.0337 0.7334 0.0440
BT-20 Ruxolitinib
3.33
uM
LJP5
 0.9599 0.0445 0.9420 0.0635
BT-20 XL147
3.33
uM
LJP5
 0.8869 0.0034 0.8362 0.0045
BT-20 Saracatinib
3.33
uM
LJP6
 0.6918 0.0542 0.5565 0.0710
BT-20 Selumetinib
3.33
uM
LJP6
 0.9603 0.0441 0.9426 0.0627
BT-20 Sirolimus
3.33
uM
LJP6
 0.6324 0.0177 0.4669 0.0302
BT-20 Sorafenib
3.33
uM
LJP6
 0.8497 0.0191 0.7833 0.0237
BT-20 SU11274
3.33
uM
LJP5
 0.8631 0.0063 0.8017 0.0083
BT-20 Fedratinib
3.33
uM
LJP5
 0.7147 0.0191 0.5876 0.0198
BT-20 TGX221
3.33
uM
LJP5
 1.0665 0.0291 1.0967 0.0420
BT-20 Torin1
3.33
uM
LJP6
 0.2362 0.0192 -0.1058 0.0061
BT-20 Torin2
3.33
uM
LJP5
 0.1736 0.0093 -0.1981 0.0345
BT-20 Tozasertib
3.33
uM
LJP5
 0.2920 0.0186 -0.0271 0.0476
BT-20 Trametinib
3.33
uM
LJP5
 0.7554 0.0153 0.6464 0.0155
BT-20 TWS119
3.33
uM
LJP5
 0.7672 0.0464 0.6645 0.0618
BT-20 Vemurafenib
3.33
uM
LJP5
 0.9078 0.0140 0.8665 0.0198
BT-20 Withaferin A
3.33
uM
LJP5
 0.1596 0.0044 -0.2179 0.0215
BT-20 Withaferin A
3.33
uM
LJP6
 0.1443 0.0106 -0.2405 0.0374
BT-20 WYE-125132
3.33
uM
LJP6
 0.3705 0.0305 0.0889 0.0345
BT-20 WZ3105
3.33
uM
LJP5
 0.1902 0.0342 -0.1751 0.0700
BT-20 XMD11-50
3.33
uM
LJP6
 0.6419 0.0602 0.4845 0.0779
BT-20 Y39983
3.33
uM
LJP6
 0.8232 0.0473 0.7465 0.0647
BT-20 YM 201636
3.33
uM
LJP5
 0.6763 0.0341 0.5319 0.0441
BT-20 ZSTK474
3.33
uM
LJP6
 0.3536 0.0607 0.0667 0.0708